Division of Developmental Medicine, Boston Children's Hospital, Boston, MA.
Department of Neurology and Developmental Medical Center, Boston Children's Hospital, Boston, MA.
J Dev Behav Pediatr. 2023 Aug 1;44(6):e444-e446. doi: 10.1097/DBP.0000000000001199. Epub 2023 Jun 22.
A.Z. is a 14-year-old young boy with Down syndrome and intellectual disability. As a baby and toddler, A.Z. struggled with swallowing dysfunction and recurrent aspiration, which improved by the time he was school aged. At the age of 2 years, his body mass index (BMI) was 95.98% (Z score 1.75). During his early school-age years, A.Z. began eating a wider variety of foods. As he grew taller and remained active, his BMI improved briefly during this time. Between ages 10 and 12 years, concerns regarding increased appetite and excessive weight gain emerged. His BMI increased from 82.56% (Z score 0.94) to 98.27% (Z score 2.11) during this time. He became insatiable; he ate when he was happy, upset, or bored. He had a compulsive need to eat all day, which escalated while staying home during the COVID pandemic. Despite having complete meals and a variety of snacks, he overate and sought out food and snacks, no matter the time of the day. Food also became a source of contention and a trigger for verbally and physically aggressive behavior when parents attempted to restrict food intake. Behavioral therapy was recommended to address his eating patterns as a part of his behavioral management plan.Over time, many strategies were used, including a token economy reward system, setting firm limits around snacking and meals, creating a food schedule with times and forced choice options, use of coping skill training, a feelings thermometer, and communication supports. These interventions had moderate intermittent success; however, overeating and consequent power struggles continued to be the major challenge reported by the family.He was started on a long-acting stimulant medication daily, intended to address impulsive and aggressive behaviors, and with potential benefit of appetite reduction. However, although there were some improvements in behavior, there was little to no effect noted on his appetite. Of note, he was diagnosed with celiac disease and severe obstructive sleep apnea at this time. A.Z. remained compliant with his gluten-free diet despite the challenges he experienced with food seeking and portion control. Overall, despite making excellent progress in behavioral regulation and performing particularly well in structured settings outside the home (i.e., school or summer camp), A.Z. continued to binge eat and seek out food with his most recent BMI at 98.62% (Z score 2.20).CASE 2: C.J. is a 9-year-old boy with Down syndrome and intellectual disability. As a toddler, C.J. had a brief period of time in which he was noted to overeat or not sense when he was full and subsequently gag or vomit after meals. At age 5 to 6 years, C.J. began demonstrating a more voracious appetite and increased weight gain; his BMI was 99.43% (Z score 2.53). Behavioral strategies, such as food schedules with forced choice options, were recommended. C.J. responded with increased dysregulation to the limit setting. An additional trigger for C.J. was the irregular visitation schedule with his father. He also hid and hoarded food; for example, he often ate food and hid the wrappers in the trash. Locking the refrigerator and cabinets resulted in binging on whatever he could find, such as ketchup packets. If C.J. wanted food during a time outside of his schedule, he was provided a list of alternative activities to choose from. It was recommended that his parent portion foods for him and set clear expectations of eating in the kitchen alone.C.J. was trialed on a short-acting alpha-agonist agent for 1 year to help address some of his behavioral challenges. Despite initial improvement on this regimen, behavioral challenges reemerged, and his eating behaviors worsened, so the medication was stopped. After stopping the medication, C.J. responded well to the limit setting, including regulating his own portion sizes and using a portion control plate. The family believed that the short-acting alpha-agonist worsened his food-seeking behaviors, although this was not clinically apparent. Despite having continued affinity for certain foods and snacks, C.J. was no longer binge eating or hoarding and hiding food. His most recent BMI remained elevated at 99.24% (Z score 2.43).
A.Z. 是一个 14 岁的唐氏综合征男孩,伴有智力障碍。在婴儿和幼儿时期,A.Z. 存在吞咽功能障碍和反复呛咳,到上学年龄时有所改善。2 岁时,他的体重指数(BMI)为 95.98%(Z 评分 1.75)。在他的早期学龄期,A.Z. 开始食用更多种类的食物。随着他长高并保持活跃,他的 BMI 在这段时间短暂改善。在 10 到 12 岁之间,人们开始关注他食欲增加和体重过度增加的问题。他的 BMI 从 82.56%(Z 评分 0.94)增加到 98.27%(Z 评分 2.11)。他变得贪得无厌;他高兴、难过或无聊时都会吃东西。他有一种强迫性的需要,整天都想吃东西,这种情况在 COVID 大流行期间在家中时更为严重。尽管他吃了完整的饭菜和各种零食,但他还是会暴饮暴食,并寻找食物和零食,无论一天中的什么时间。当父母试图限制食物摄入量时,食物也成为了引发他言语和身体攻击行为的导火索。建议对他的饮食模式进行行为治疗,作为他行为管理计划的一部分。随着时间的推移,使用了许多策略,包括代币经济奖励系统、严格限制零食和正餐、制定包含时间和强制选择选项的饮食时间表、使用应对技能训练、情绪温度计和沟通支持。这些干预措施取得了一定的间歇性成功;然而,过度饮食和随之而来的权力斗争仍然是家庭报告的主要挑战。他开始每天服用长效兴奋剂药物,旨在解决冲动和攻击行为,同时可能有助于减少食欲。然而,尽管他的行为有所改善,但对他的食欲几乎没有影响。值得注意的是,此时他被诊断出患有乳糜泻和严重阻塞性睡眠呼吸暂停。尽管 A.Z. 在寻找食物和控制食物分量方面遇到了挑战,但他仍坚持无麸质饮食。总的来说,尽管在行为调节方面取得了出色的进展,并且在家庭以外的结构化环境(例如学校或夏令营)中表现出色,但 A.Z. 仍继续暴食并寻找食物,他最近的 BMI 为 98.62%(Z 评分 2.20)。
案例 2:C.J. 是一个 9 岁的唐氏综合征男孩,伴有智力障碍。在幼儿时期,C.J. 有一段时间吃得过多或无法感知饱腹感,然后在饭后会呛咳或呕吐。在 5 到 6 岁时,C.J. 开始表现出更强烈的食欲和体重增加;他的 BMI 为 99.43%(Z 评分 2.53)。建议采用饮食时间表和强制选择选项等行为策略。C.J. 对限制设定的反应更加失调。C.J. 的另一个触发因素是与父亲不规律的探视时间。他还会藏匿和囤积食物;例如,他经常吃食物并将包装藏在垃圾桶里。锁住冰箱和柜子会导致他在任何他能找到的食物上暴食,例如番茄酱包。如果 C.J. 在规定时间之外想吃东西,会给他提供一份可供选择的活动清单。建议他的父母给他分好食物,并明确规定在厨房独自进食的要求。C.J. 尝试了一种短效的α-激动剂药物治疗,为期 1 年,以帮助解决他的一些行为挑战。尽管这种治疗方案最初有一定效果,但行为挑战再次出现,他的饮食行为恶化,因此停止了药物治疗。停止药物治疗后,C.J. 对限制设定的反应良好,包括控制自己的食物份量和使用份量控制盘。家人认为短效α-激动剂恶化了他的寻食行为,尽管这在临床上并不明显。尽管 C.J. 仍然喜欢某些食物和零食,但他不再暴食或藏匿和隐藏食物。他最近的 BMI 仍保持在 99.24%(Z 评分 2.43)。